Johnson & Johnson (JNJ) Tops Q2 EPS by 12c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Johnson & Johnson (JNJ) PT Lowered to $146 at Raymond James
July 17, 2019 7:12 AM EDTRaymond James analyst Jayson Bedford lowered the price target on Johnson & Johnson (NYSE: JNJ) to $146.00 (from $147.00) while maintaining an Outperform rating.
Still a Lot of Drama, but Solid Fundamentals, Attractive Valuation
... More